Today is September 20, 2024. All times in Eastern Daylight Time.
Canlak Coatings Announces New Chief Executive Officer
09/20/2024 - 02:00 PM
BUSINESS WIRE
CFP Board Imposes Public Sanctions on Five Individuals
09/20/2024 - 02:00 PM
BUSINESS WIRE
AM Best Affirms Credit Ratings of Ascot Group Limited’s Core Operating Subsidiaries
09/20/2024 - 01:59 PM
BUSINESS WIRE
Riassunto: Neu-REFIX Beta glucan riceve dall'FDA statunitense le designazioni di farmaco orfano e per malattia rara pediatrica per il trattamento della distrofia muscolare di Duchenne
09/20/2024 - 01:40 PM
BUSINESS WIRE
Neu-REFIX Beta葡聚糖獲美國食品藥物管理局的罕見兒科疾病認定和孤兒藥認定,用於治療裘馨氏肌肉失養症
09/20/2024 - 01:37 PM
BUSINESS WIRE
HPE Named a Leader in the 2024 Gartner® Magic Quadrant™ for Primary Storage Platforms
09/20/2024 - 01:37 PM
BUSINESS WIRE
Neu-REFIX Beta葡聚糖获得美国FDA罕见儿科疾病和孤儿药认定,可用于治疗杜氏肌营养不良症
09/20/2024 - 01:33 PM
BUSINESS WIRE
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against GitLab Inc. (GTLB)
09/20/2024 - 01:29 PM
BUSINESS WIRE
Samenvatting: Neu-REFIX Beta glucan ontvangt van de Amerikaanse FDA de benaming voor zeldzame ziekten bij kinderen en het statuut weesgeneesmiddel voor de behandeling van Duchenne spierdystrofie
09/20/2024 - 01:26 PM
BUSINESS WIRE
El betaglucano Neu-REFIX recibe las designaciones de enfermedad pediátrica rara y medicamento huérfano de la FDA de EE. UU. para el tratamiento de la distrofia muscular de Duchenne
09/20/2024 - 01:23 PM
BUSINESS WIRE
1
2
3
4
5
6
7
8
9
10
11
...
1483
« Previous
Next »